Exfoliative dermatitis - Dermatitis Exfoliative
☆ Yng nghanlyniadau Stiftung Warentest 2022 o’r Almaen, roedd boddhad defnyddwyr â ModelDerm ond ychydig yn is nag ymgynghoriadau telefeddygaeth taledig.
Red (burning) Skin Syndrome ― Erythema a graddfa ar y corff cyfan yw prif symptomau Dermatitis Exfoliative (Exfoliative dermatitis).
References
Mae Erythroderma yn gyflwr croen prin ond difrifol. Er bod yr union achos yn aml yn anhysbys, gall gael ei sbarduno gan adwaith cyffuriau neu ganser sylfaenol. Un canser cyffredin sy'n gysylltiedig â dermatitis exfoliative yw lymffoma celloedd T y croen, na fydd efallai'n dangos symptomau am fisoedd neu hyd yn oed flynyddoedd ar ôl i gyflwr y croen ddechrau. Fel arfer, mae angen mynd i'r ysbyty ar gyfer asesiad cychwynnol a thriniaeth. Yn gyffredinol, mae gan gleifion â chlefydau a achosir gan gyffuriau ragolygon hirdymor da, er bod achosion heb achos clir yn tueddu i fod â chwrs cylchol a chylchol. Mae'r prognosis ar gyfer achosion sy'n gysylltiedig â chanser fel arfer yn dibynnu ar sut mae'r canser yn datblygu.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Yn nodweddiadol mae'n dangos cochni eang a fflawio sy'n gorchuddio dros 90% o'r corff. Mae'r cyflwr hwn yn arwydd gweladwy o faterion iechyd sylfaenol amrywiol fel soriasis, ecsema, neu ymateb i rai meddyginiaethau.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
Achos mwyaf cyffredin erythroderma yw gwaethygu clefyd croen gwaelodol, megis soriasis, dermatitis cyswllt, dermatitis seborrheic, planws cen, pityriasis rubra pilaris neu adwaith cyffuriau, megis defnyddio steroidau argroenol. Mae manefest sylfaenol yn llai aml ac fe'i gwelir fel arfer mewn achosion o lymffoma celloedd T croenol. Oherwydd ei bod yn bwysig ei wahaniaethu oddi wrth lymffoma celloedd T croenol, cynhelir biopsi.